Bewertung einer Infusionbehandlung der rheumatoiden Arthritis durch Patienten und Rheumatologen-Reference-Cited by-同舟云学术

Bewertung einer Infusionbehandlung der rheumatoiden Arthritis durch Patienten und Rheumatologen

Published:2011-02-27 Issue:3 Volume:70 Page:232-238
ISSN:0340-1855
Container-title:Zeitschrift für Rheumatologie
language:de
Short-container-title:Z. Rheumatol.

Author:

Willeke P.,Becker H.,Wassenberg S.,Pavenstädt H.,Jacobi A.M.

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00393-011-0752-3.pdf

Reference16 articles.

1. Du Pan SM, Dehler S, Ciurea A et al (2009) Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis. Arthritis Rheum 61:560–568

2. Singh JA, Christensen R, Wells GA et al (2009) Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev:CD007848

3. Cohen SB, Emery P, Greenwald MW et al (2006) Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 54:2793–2806

4. Jacobi AM, Dorner T (2010) Current aspects of anti-CD20 therapy in rheumatoid arthritis. Curr Opin Pharmacol 10:316–321

5. Schmidt WA, Schicke B, Krause A et al (2010) Wie wirksam ist Rituximab bei der rheumatoiden Arthritis? Z Rheumatol 69:349–355

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparing Patient Preference Between At-home and In-hospital Settings: Systematic Review and Meta-Analysis on Injectable Medications;Archives of Pharmacy Practice;2023

2. Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic Review;Patient Preference and Adherence;2021-04

Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ©)

;Patient Preference and Adherence;2020-04

4. Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases;Patient Preference and Adherence;2018-10

5. A Nationwide Survey on Patient’s versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study;PLOS ONE;2016-11-28